Many sick-care institutions are grappling with whether to make or buy innovation. The makers are trying to bring their innovation structure and processes in house, while the buyers are partnering with other entities, like industry, entrepreneurs and investors, to outsource or take primary responsibility for the results, usually in the form of accelerators or incubators. Both have their detractors and critics, while some are claiming impressive success. – See more at: http://www.hcplive.com/physicians-money-digest/contributor/arlen-meyers-md-mba/2016/04/innovation-grappling-with-the-make-or-buy-decision#sthash.9GLF6Rg7.dpuf
Últimas noticias
Lea lo último sobre SoPE, innovación sanitaria e investigación médica